Metabolic Syndrome Market Insights Video

According to Cognitive Market Research, the global Metabolic Syndrome market size is USD 25142.2 million in 2024 and will expand at a compound annual growth rate (CAGR) of 5.00% from 2024 to 2031.

• North America held the major market of more than 40% of the global revenue with a market size of USD 10056.88 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.2% from 2024 to 2031.
• Europe accounted for a share of over 30% of the global market size of USD 7542.66 million.
• Asia Pacific held the market of around 23% of the global revenue with a market size of USD 5782.71 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2031.
• Latin America hols the market of more than 5% of the global revenue with a market size of USD 1257.11 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.4% from 2024 to 2031.
• Middle East and Africa held the market of around 2% of the global revenue with a market size of USD 502.84 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.7% from 2024 to 2031.
• The dominant category in the Metabolic Syndrome Market for Route of Administration is Oral. Oral medications are the most common route of administration for treating metabolic syndrome due to their convenience, ease of use, and patient compliance.